Eminase (Wulfing Pharma GmbH) en es it fr

Eminase (Wulfing Pharma GmbH) Brand names, Eminase (Wulfing Pharma GmbH) Analogs

Eminase (Wulfing Pharma GmbH) Brand Names Mixture

  • Synotic Otic Solution (Dimethyl sulfoxide + Fluocinolone acetonide)

Eminase (Wulfing Pharma GmbH) Chemical_Formula

C2569H3928N746O781S40

Eminase (Wulfing Pharma GmbH) RX_link

No information avaliable

Eminase (Wulfing Pharma GmbH) fda sheet

Eminase (Wulfing Pharma GmbH) msds (material safety sheet)

Eminase (Wulfing Pharma GmbH) Synthesis Reference

No information avaliable

Eminase (Wulfing Pharma GmbH) Molecular Weight

59042.3

Eminase (Wulfing Pharma GmbH) Melting Point

60 oC (Novokhatny, V.V. et al., J. Biol. Chem. 266:12994-123002 (1991))

Eminase (Wulfing Pharma GmbH) H2O Solubility

No information avaliable

Eminase (Wulfing Pharma GmbH) State

Liquid

Eminase (Wulfing Pharma GmbH) LogP

-0.516

Eminase (Wulfing Pharma GmbH) Dosage Forms

Powder for solution

Eminase (Wulfing Pharma GmbH) Indication

For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction

Eminase (Wulfing Pharma GmbH) Pharmacology

Anistreplase cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction.

Eminase (Wulfing Pharma GmbH) Absorption

No information avaliable

Eminase (Wulfing Pharma GmbH) side effects and Toxicity

No information avaliable

Eminase (Wulfing Pharma GmbH) Patient Information

No information avaliable

Eminase (Wulfing Pharma GmbH) Organisms Affected

Humans and other mammals